The use of prognosis scoring systems to time donor stem cell transplantation may extend the lives of patients treated for myelodysplastic syndromes, according to a study in the American Journal of Hematology. Researchers in Italy found that delayed transplantation may be better for patients whose early illness is considered very low- or low-risk by the World Health Organization classification-based Prognostic Scoring System and low-risk by the International Prognostic Scoring System.
Scoring systems improve timing of cell transplant for MDS patients
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|